August 2016
Antithrombin alfa (ATryn) for pre-eclampsia in pre-term women
Pre-eclampsia is a condition that affects some pregnant women during the second half of their pregnancy. Signs include high blood pressure and protein in the urine. Most cases are mild, but the condition can lead to serious complications for both mother and baby. Antithrombin alfa is a new drug for the treatment of pre-eclampsia that …
October 2012
UPDATED: Amniotic Fluid Lactate™ monitoring system for dysfunctional labour
The Amniotic Fluid Lactate™ (AFL) monitoring system is designed to aid clinical decisions during dysfunctional labour. It consists of a monitor and a probe which measures the level of lactate in the amniotic fluid. This correlates with lactate levels in the uterus. High uterine lactate levels may indicate that treatment with oxytocin would be less …
September 2012
UPDATED: Placental Growth Factor based tests for the diagnosis of pre-eclampsia
The Alere PlGF test and the Roche sFlt-1/PlGF ratio test may provide a new way of diagnosing pre-eclampsia in pregnant women who have signs and symptoms of the condition. The Alere PlGF test measures a biomarker called placental growth factor (PlGF) and the Roche sFlt-1/PlGF ratio test measures PlGF and soluble FMS-like tyrosine kinase-1 (sFlt-1) …
